wasting and the lymphoid atrophy and degeneration (GVHD) is mainly produced by T cytotoxic cells (Tc) reacting to KID. This assumption is not supported by findings with H-2 mutants (Klein 1978) .
Most known H-2 mutants are K or D locus mutants. Surprisingly, the stimulus provided by such mutant hosts to grafted wild-type cells is often stronger in terms of GVHD than when the host stimulus is provided by a fully allogeneic K or D product presented by a recombinant host, H-2 haplotype. IfGVHD is predominantly related to the Tc, it would be anticipated that cell-mediated Iympholysis was particularly strong in response to these mutants, but this has not been found. In contrast, H-2 K and D mutants were usually better stimulators in mixed lymphocyte reactions than the corresponding recombinants. This suggests that the Th responses are at least as important as Tc responses in determining GVHD.
In these H-2 mutant' experiments, a smaller chemical change seems to give the larger effect. H-2 mutants are mostly single point mutations in one or two codons of the entire heavy chain gene, while H-2 recombinants presumably represent more extensive molecular differences. The reason for this paradoxical relationship is not clear. MHC antigens activate many different clones, particularly large fractions of the T cell population.
H antigens not belonging to MHC may also provoke GVHR, but even the concerted action of several of these 'weak' antigens are less powerful than the action of a single MHC allelic difference. It is unlikely that any normal mouse, rat or chicken has ever been killed by non-MHC as the sole stimulant to GVHD. In man, it may unfortunately be different, although the strictly relevant data do not exist, as normal people are not exposed to such risks.
Ways of avoiding GVHR and GVHD
. Twenty-five years ago, I advocated the grafting of embryonic spleen cells which should in theory become tolerant of their hosts and yet develop normal reactivity to other antigens with which the immunodeficient could not cope. This was based on the discovery of acquired tolerance by Billingham et al. (1956) . However, there are other and probably better ways of avoiding GVHD. There are experimental strategies which aim at providing lethally irradiated 'recipients with fully MHC-allogeneic bone marrow specifically devoid of T cells reacting against the host. Although this work has a long history, substantial credit should go to Miiller-Ruchholtz and colleagues. This group established a few years ago that permanent and apparently healthy chimeras could be regularly produced with near 100% success by the use of SAL, (Miiller-Ruchholtz & Miiller-Hermelink 1980) , which is suitably absorbed rabbit antirat thymus antiserum. They have recently shown that the very same SAL can also be used in mice with the net effect that lethally X-rayed Balb/c mice are regularly and so far permanently restored by SAL-treated bone marrow from C3H (Miiller-Ruchholtz et al. 1981) . Unlike their rat into rat chimeras, which are about 50% donor and' 50% host in a stable lymphoid cell mixture, the new mouse chimeras show a complete takeover of the graft in bone marrow, thymus, spleen, and lymph nodes. These animals are fully tolerant to skin from the C3H donor and reject acutely third party C57 skin grafts. Thereafter, they can be shown to contain cytotoxic cells to C57, but not to the donor and host strains. In vitro cooperation has not yet been shown. The mode of production of SAL is by absorbing the rabbit anti-rat ATS sequentially with erythrocytes, peritoneal non-lymphoid cells and embryonic liver, all of rat origin. SAL eliminated not only mature T cells but apparently also T .cell precursors which presumably share a differentiation antigen, probably not Thy-I.
The demonstration that an antiserum from a purely xenogenic system, rabbit anti-rat, can be employed successfully in mice, makes this into a model system with potential clinical application, besides being a research tool to study the problem of genetic and ontogenetic requirements for cell cooperation. Meanwhile, probably inspired by Miiller-Ruchholtz's rat chimeras, Onoe et al. (1980) have recently published studies in mice in which permanent and apparently very healthy, full H-2 different chimeras have been produced by pretreating the bone marrow graft with a strong anti-Thy-l serum. It is quite possible that the two groups are in fact eliminating both mature and immature T cells sharing one or more differentiation antigens absent in the bone marrow progenitor which survive the antiserum treatment. This hypothesis does imply that complete tolerance induction requires exposure to MHC antigen prior to the expression of this hypothetical differentiation antigen.
In the case of the chimeras of Onoe et of. (1980) , analysis has shown that the primary response to sheep red blood cells is grossly deficient, whereas the secondary response is near normal, albeit with some amount of preference for IgM plaques. As yet there is no indication from any of these chimeric mice, that maturing T cells become truly forgetful of their genetic self by education in a fully foreign thymus'. This conclusion offers good grounds for optimism for the eventual availability of an acceptable bone marrow donor in clinical transplantation.
